These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12351412)

  • 1. PML-RAR induces promyelocytic leukemias with high efficiency following retroviral gene transfer into purified murine hematopoietic progenitors.
    Minucci S; Monestiroli S; Giavara S; Ronzoni S; Marchesi F; Insinga A; Diverio D; Gasparini P; Capillo M; Colombo E; Matteucci C; Contegno F; Lo-Coco F; Scanziani E; Gobbi A; Pelicci PG
    Blood; 2002 Oct; 100(8):2989-95. PubMed ID: 12351412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
    Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon augments PML and PML/RAR alpha expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell line.
    Nason-Burchenal K; Gandini D; Botto M; Allopenna J; Seale JR; Cross NC; Goldman JM; Dmitrovsky E; Pandolfi PP
    Blood; 1996 Nov; 88(10):3926-36. PubMed ID: 8916959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of wild-type retinoic acid receptor alpha (RARalpha) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by acute promyelocytic leukemia RARalpha-fusion genes.
    Du C; Redner RL; Cooke MP; Lavau C
    Blood; 1999 Jul; 94(2):793-802. PubMed ID: 10397747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation.
    Shao W; Benedetti L; Lamph WW; Nervi C; Miller WH
    Blood; 1997 Jun; 89(12):4282-9. PubMed ID: 9192750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences.
    Grisolano JL; Wesselschmidt RL; Pelicci PG; Ley TJ
    Blood; 1997 Jan; 89(2):376-87. PubMed ID: 9002938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PML/RAR alpha fusion protein expression in normal human hematopoietic progenitors dictates myeloid commitment and the promyelocytic phenotype.
    Grignani F; Valtieri M; Gabbianelli M; Gelmetti V; Botta R; Luchetti L; Masella B; Morsilli O; Pelosi E; Samoggia P; Pelicci PG; Peschle C
    Blood; 2000 Aug; 96(4):1531-7. PubMed ID: 10942402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia.
    Riccioni R; Saulle E; Militi S; Sposi NM; Gualtiero M; Mauro N; Mancini M; Diverio D; Lo Coco F; Peschle C; Testa U
    Leukemia; 2003 Jan; 17(1):98-113. PubMed ID: 12529666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoic acid receptor alpha fusion to PML affects its transcriptional and chromatin-remodeling properties.
    Segalla S; Rinaldi L; Kilstrup-Nielsen C; Badaracco G; Minucci S; Pelicci PG; Landsberger N
    Mol Cell Biol; 2003 Dec; 23(23):8795-808. PubMed ID: 14612419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular genetics of acute promyelocytic leukemia.
    Grignani F; Fagioli M; Ferrucci PF; Alcalay M; Pelicci PG
    Blood Rev; 1993 Jun; 7(2):87-93. PubMed ID: 8396481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of the PML/RAR alpha rearrangement in acute promyelocytic leukemia using a reverse PCR method].
    Barragán E; Bonanad S; López JA; Martín G; Martínez J; Sanz GF; Gomis F; Pérez ML; Senent ML; Larrea L; Bolufer P; Sanz MA
    Sangre (Barc); 1996 Jun; 41(3):189-94. PubMed ID: 8755206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the PML/RAR alpha translocation product triggers apoptosis in promyelocytic leukemia cells.
    Nason-Burchenal K; Takle G; Pace U; Flynn S; Allopenna J; Martin P; George ST; Goldberg AR; Dmitrovsky E
    Oncogene; 1998 Oct; 17(14):1759-68. PubMed ID: 9778041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signalling.
    Ruthardt M; Testa U; Nervi C; Ferrucci PF; Grignani F; Puccetti E; Grignani F; Peschle C; Pelicci PG
    Mol Cell Biol; 1997 Aug; 17(8):4859-69. PubMed ID: 9234742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.
    Rego EM; Ruggero D; Tribioli C; Cattoretti G; Kogan S; Redner RL; Pandolfi PP
    Oncogene; 2006 Mar; 25(13):1974-9. PubMed ID: 16331271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Basic and clinical studies of the gene product-targeting therapy based on leukemogenesis--editorial].
    Chen SJ; Chen LJ; Zhou GB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):1-8. PubMed ID: 15748426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trivalent antimonials induce degradation of the PML-RAR oncoprotein and reorganization of the promyelocytic leukemia nuclear bodies in acute promyelocytic leukemia NB4 cells.
    Müller S; Miller WH; Dejean A
    Blood; 1998 Dec; 92(11):4308-16. PubMed ID: 9834237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.
    Grimwade D; Solomon E
    Curr Top Microbiol Immunol; 1997; 220():81-112. PubMed ID: 9103677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657.
    Sohal J; Phan VT; Chan PV; Davis EM; Patel B; Kelly LM; Abrams TJ; O'Farrell AM; Gilliland DG; Le Beau MM; Kogan SC
    Blood; 2003 Apr; 101(8):3188-97. PubMed ID: 12515727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PML/RARalpha, a fusion protein in acute promyelocytic leukemia, prevents growth factor withdrawal-induced apoptosis in TF-1 cells.
    Fu S; Consoli U; Hanania EG; Zu Z; Claxton DF; Andreeff M; Deisseroth AB
    Clin Cancer Res; 1995 Jun; 1(6):583-90. PubMed ID: 9816019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice.
    He LZ; Tribioli C; Rivi R; Peruzzi D; Pelicci PG; Soares V; Cattoretti G; Pandolfi PP
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5302-7. PubMed ID: 9144232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.